Cannabis in Pain Treatment: Clinical and Research Considerations

Journal of Pain

Volumn 17, Issue 6, 2016, Pages 654-668

  Savage, Seddon R ^a,b   Romero Sandoval, Alfonso ^c   Schatman, Michael ^d   Wallace, Mark ^e   Fanciullo, Gilbert ^a   McCarberg, Bill ^e   Ware, Mark ^f  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b SILVER HILL HOSPITAL   (United States)

^c PRESBYTERIAN COLLEGE   (United States)

^d US Pain Foundation   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Cannabis; marijuana

Indexed keywords

CANNABINOID; CANNABIS; ENDOCANNABINOID;

BEHAVIOR; CANCER RISK; CANNABIS SMOKING; CARDIOPULMONARY FUNCTION; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COUNSELING; DRUG MISUSE; HUMAN; LAW; MEDICOLEGAL ASPECT; PAIN; POLICY; PUBLIC HEALTH; RESPONSIBILITY; REVIEW; RISK; SIDE EFFECT; THERAPY EFFECT; UNITED STATES; ANALGESIA; ANIMAL; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; BIOMEDICAL RESEARCH; CANNABINOIDS; CLINICAL TRIALS AS TOPIC; HUMANS; PAIN; PAIN MANAGEMENT; UNITED STATES;

EID: 84963958013     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2016.02.007     Document Type: Article

References (112)

1. D.I. Abrams, P. Couey, S.B. Shade, M.E. Kelly, and N.L. Benowitz Cannabinoid-opioid interaction in chronic pain Clin Pharmacol Ther 90 2011 844 851
2. D.I. Abrams, C.A. Jay, S.B. Shade, H. Vizoso, H. Reda, S. Press, M.E. Kelly, M.C. Rowbotham, and K.L. Petersen Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial Neurology 68 2007 515 521
3. E.Y. Adashi, and R.P. Kocher Physician self-referral: Regulation by exceptions JAMA 313 2015 457 458
4. American Medical Association: H-95.952 Cannabis for Medicinal Use. Available at: https://www.ama-assn.org/ssl3/ecomm/PolicyFinderForm.pl?site= www.ama-assn.org&uri=/resources/html/PolicyFinder/policyfiles/HnE/H-95.952.HTM. Accessed January 14, 2016
5. American Medical Association: Opinion 8.08 Informed Consent. Available at: http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion808.page. Accessed July 21, 2015
6. M.H. Andreae, G.M. Carter, N. Shaparin, K. Suslov, R.J. Ellis, M.A. Ware, D.I. Abrams, H. Prasad, B. Wilsey, D. Indyk, M. Johnson, and H.S. Sacks Inhaled cannabis for chronic neuropathic pain: A meta-analysis of individual patient data J Pain 16 2015 1221 1232
7. J.C. Anthony The epidemiology of cannabis dependence R.A. Roffman, R.S. Stephens, Cannabis Dependence: Its Nature, Consequences and Treatment 2006 Cambridge University Press Cambridge 58 105
8. Arizona Department of Health Services. University of Arizona, College of Public Health: Contract No: ADHS12-017291. Report to Arizona Department of Health Services: First Annual Medical Marijuana Report A.R.S. §36-2809. Available at: http://archive.azcentral.com/ic/pdf/MM-annual-final-report.pdf. Accessed March 28, 2015
9. M. Asbridge, J.A. Hayden, and J.L. Cartwright Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis BMJ 344 2012 e536
10. Azcentral. Billeaud J: 24 Doctors certify most in Ariz.'s pot program. Available at: http://www.azcentral.com/news/free/20121109arizona-marijuana-program-doctors.html. Accessed July 21, 2015
11. M.A. Bachhuber, B. Saloner, C.O. Cunningham, and C.L. Barry Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 JAMA Intern Med 174 2014 1668 1673
12. A.M. Bakheit The pharmacological management of post-stroke muscle spasticity Drugs Aging 29 2012 941 947
13. Beaver WT, Buring J, Goldstein A, Johnson K, Jones R, Kris MC, Mooney K, Palmberg P, Phair J: Report to the Director, National Institutes of Health. Available at: http://www.sky.org/data/laaketiede/MedicalMJ.html. Accessed July 21, 2015
14. D.R. Blake, P. Robson, M. Ho, R.W. Jubb, and C.S. McCabe Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis Rheumatology (Oxford) 45 2006 50 52
15. Bureau voor Medicinale Cannabis [Office for Medicinal Cannabis]: Available at: https://www.cannabisbureau.nl/english. Accessed July 21, 2015
16. T.L. Burns, and J.R. Ineck Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain Ann Pharmacother 40 2006 251 260
17. M. Cerda, M. Wall, K.M. Keyes, S. Galea, and D. Hasin Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence Drug Alcohol Depend 120 2012 22 27
18. ClinicalTrials.gov. Available at: https://clinicaltrials.gov. Accessed March 29, 2016
19. ClinicalTrials.gov: Vaporized Cannabis and Spinal Cord Injury Pain. Available at: https://clinicaltrials.gov/ct2/show/NCT01555983. Accessed July 21, 2015
20. P.J. Cohen Medical marijuana: The conflict between scientific evidence and political ideology. Part one of two J Pain Palliat Care Pharmacother 23 2009 4 25
21. P.J. Cohen Medical marijuana: The conflict between scientific evidence and political ideology. Part two of two J Pain Palliat Care Pharmacother 23 2009 120 140
22. Colorado Department of Public Health & Environment: Approved medical marijuana research grants. Available at: https://www.colorado.gov/pacific/cdphe/approved-medical-marijuana-research-grants. Accessed July 21, 2015
23. Congressional Research Service. CRS Report for Congress. Eddy M: Medical Marijuana: Review and Analysis of Federal and State Policies. Available at: http://fas.org/sgp/crs/misc/RL33211.pdf. Accessed March 28, 2015
24. Z.D. Cooper, S.D. Comer, and M. Haney Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers Neuropsychopharmacology 38 2013 1984 1992
25. R.D. Crean, S.F. Tapert, A. Minassian, K. Macdonald, N.A. Crane, and B.J. Mason Effects of chronic, heavy cannabis use on executive functions J Addict Med 5 2011 9 15
26. B.J. Cridge, and R.J. Rosengren Critical appraisal of the potential use of cannabinoids in cancer management Cancer Manag Res 5 2013 301 313
27. E. Eisenberg, M. Ogintz, and S. Almog The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study J Pain Palliat Care Pharmacother 28 2014 216 225
28. R.J. Ellis, W. Toperoff, F. Vaida, G. van den Brande, J. Gonzales, B. Gouaux, H. Bentley, and J.H. Atkinson Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial Neuropsychopharmacology 34 2009 672 680
29. ElSohly MA: National Institute on Drug Abuse, Quarterly Report: Potency Monitoring Project. Available at: https://www.ncjrs.gov/pdffiles1/ondcp/mpmp-report-104.pdf. Accessed March 28, 2015
30. M.D. Finkelman, R.J. Kulich, K.L. Zacharoff, N. Smits, B.E. Magnuson, J. Dong, and S.F. Butler Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A proof-of-principle study for customized computer-based testing Pain Med 16 2015 2344 2356
31. J.A. Farrimond, M.S. Mercier, B.J. Whalley, and C.M. Williams Cannabis sativa and the endogenous cannabinoid system: Therapeutic potential for appetite regulation Phytother Res 25 2011 170 188
32. J. Gertsch, R.G. Pertwee, and V. Di Marzo Phytocannabinoids beyond the Cannabis plant - do they exist? Br J Pharmacol 160 2010 523 529
33. D.L. Gourlay, H.A. Heit, and A. Almahrezi Universal precautions in pain medicine: A rational approach to the treatment of chronic pain Pain Med 6 2005 107 112
34. F. Grotenhermen Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 42 2003 327 360
35. J. Guindon, and A.G. Hohmann The endocannabinoid system and pain CNS Neurol Disord Drug Targets 8 2009 403 421
36. R.L. Hartman, and M.A. Huestis Cannabis effects on driving skills Clin Chem 59 2013 478 492
37. A. Hazekamp, R. Ruhaak, L. Zuurman, J. van Gerven, and R. Verpoorte Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol J Pharm Sci 95 2006 1308 1317
38. Health Canada: Licensed Producers. Available at: http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/index-eng.php. Accessed July 21, 2015
39. C.C. Hunault, K.B. Bocker, R.K. Stellato, J.L. Kenemans, I. de Vries, and J. Meulenbelt Acute subjective effects after smoking joints containing up to 69 mg Delta9-tetrahydrocannabinol in recreational users: A randomized, crossover clinical trial Psychopharmacology (Berl) 231 2014 4723 4733
40. M.A. Issa, S. Narang, R.N. Jamison, E. Michna, R.R. Edwards, D.M. Penetar, and A.D. Wasan The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain Clin J Pain 30 2014 472 478
41. S.C. Jaques, A. Kingsbury, P. Henshcke, C. Chomchai, S. Clews, J. Falconer, M.E. Abdel-Latif, J.M. Feller, and J.L. Oei Cannabis, the pregnant woman and her child: Weeding out the myths J Perinatol 34 2014 417 424
42. M. Joshi, A. Joshi, and T. Bartter Marijuana and lung diseases Curr Opin Pulm Med 20 2014 173 179
43. J.E. Joy, S.J. Watson Jr., and J.A. Benson Jr. Marijuana and Medicine: Assessing the Science Base 1999 National Academies Press Washington, D.C.
44. K.K. Kedzior, and L.T. Laeber A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population-a meta-analysis of 31 studies BMC Psychiatry 14 2014 136
45. E. Kondrad, and A. Reid Colorado family physicians' attitudes toward medical marijuana J Am Board Fam Med 26 2013 52 60
46. B.S. Koppel, J.C. Brust, T. Fife, J. Bronstein, S. Youssof, G. Gronseth, and D. Gloss Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology 82 2014 1556 1563
47. D.J. Kupfer, T. Detre, J. Koral, and P. Fajans A comment on the "amotivational syndrome" in marijuana smokers Am J Psychiatry 130 1973 1319 1322
48. D. Lee, E.L. Karschner, G. Milman, A.J. Barnes, R.S. Goodwin, and M.A. Huestis Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend 130 2013 68 76
49. M.H. Lee, and R.J. Hancox Effects of smoking cannabis on lung function Expert Rev Respir Med 5 2011 537 546 quiz: 547
50. Y. Le Strat, C. Dubertret, and B. Le Foll Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States Accid Anal Prev 76 2015 1 5
51. M.C. Li, J.E. Brady, C.J. DiMaggio, A.R. Lusardi, K.Y. Tzong, and G. Li Marijuana use and motor vehicle crashes Epidemiol Rev 34 2012 65 72
52. C. Lopez-Quintero, J. Perez de los Cobos, D.S. Hasin, M. Okuda, S. Wang, B.F. Grant, and C. Blanco Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Drug Alcohol Depend 115 2011 120 130
53. D.I. Lubman, A. Cheetham, and M. Yucel Cannabis and adolescent brain development Pharmacol Ther 148 2015 1 16
54. M.E. Lynch, and F. Campbell Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials Br J Clin Pharmacol 72 2011 735 744
55. M.E. Lynch, and M.A. Ware Cannabinoids for the treatment of chronic non-cancer pain: An updated systematic review of randomized controlled trials J Neuroimmune Pharmacol 10 2015 293 301
56. F.C. Machado Rocha, S.C. Stefano, R. De Cassia Haiek, L.M. Rosa Oliveira, and D.X. Da Silveira Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis Eur J Cancer Care (Engl) 17 2008 431 443
57. Marijuana Policy Project: State Policy. Available at: http://www.mpp.org/states. Accessed July 21, 2015
58. B.E. McGeeney Cannabinoids and hallucinogens for headache Headache 53 2013 447 458
59. R. Mechoulam, W.A. Devane, A. Breuer, and J. Zahalka A random walk through a cannabis field Pharmacol Biochem Behav 40 1991 461 464
60. Z. Mehmedic, S. Chandra, D. Slade, H. Denham, S. Foster, A.S. Patel, S.A. Ross, I.A. Khan, and M.A. ElSohly Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 J Forensic Sci 55 2010 1209 1217
61. T. Naftali, R. Mechulam, L.B. Lev, and F.M. Konikoff Cannabis for inflammatory bowel disease Dig Dis 32 2014 468 474
62. National Institutes of Health. Department of Health and Human Services: Notice of Availability of Additional Marijuana Strains through NIDA's Drug Supply Program. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-15-064.html. Accessed July 21, 2015
63. National Medical Marijuana Growers Association: About Us. Available at: http://www.medicalmarijuanagrowersassociation.org/#/about-us/4579354785. Accessed July 21, 2015
64. NIH. National Institute on Drug Abuse: NIDA Research on the Therapeutic Benefits of Cannabis and Cannabinoids. Available at: http://www.drugabuse.gov/drugs-abuse/marijuana/nida-research-therapeutic-benefits-cannabis-cannabinoids. Accessed July 21, 2015
65. T.J. O'Connell, and C.B. Bou-Matar Long-term marijuana users seeking medical cannabis in California (2001-2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants Harm Reduct J 4 2007 16
66. O'Connor A: Israeli Medical Marijuana Creates Buzz But No High - Will It Go Global? Available at: https://www.washingtonpost.com/world/middle-east/israeli-medical-marijuana-creates-buzz-but-no-high-will-it-go-global/2015/01/31/558fe072-a19a-11e4-9f89-561284a573f8-story.html. Accessed March 28, 2015
67. T. Passie, H.M. Emrich, M. Karst, S.D. Brandt, and J.H. Halpern Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence Drug Test Anal 4 2012 649 659
68. J.F. Peppin, S.D. Passik, J.E. Couto, P.G. Fine, P.J. Christo, C. Argoff, G.M. Aronoff, D. Bennett, M.D. Cheatle, K.A. Slevin, and N.I. Goldfarb Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain Pain Med 13 2012 886 896
69. J. Perez Combined cannabinoid therapy via an oromucosal spray Drugs Today (Barc) 42 2006 495 503
70. B.E. Perron, K. Bohnert, A.K. Perone, M.O. Bonn-Miller, and M. Ilgen Use of prescription pain medications among medical cannabis patients: Comparisons of pain levels, functioning, and patterns of alcohol and other drug use J Stud Alcohol Drugs 76 2015 406 413
71. A. Pesce, C. West, M. Rosenthal, R. West, B. Crews, C. Mikel, P. Almazan, S. Latyshev, and P.S. Horn Marijuana correlates with use of other illicit drugs in a pain patient population Pain Physician 13 2010 283 287
72. R.K. Portenoy, E.D. Ganae-Motan, S. Allende, R. Yanagihara, L. Shaiova, S. Weinstein, R. McQuade, S. Wright, and M.T. Fallon Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A randomized, placebo-controlled, graded-dose trial J Pain 13 2012 438 449
73. R. Ramer, and B. Hinz New insights into antimetastatic and antiangiogenic effects of cannabinoids Int Rev Cell Mol Biol 314 2015 43 116
74. P. Robson Therapeutic aspects of cannabis and cannabinoids Br J Psychiatry 178 2001 107 115
75. S. Rom, and Y. Persidsky Cannabinoid receptor 2: Potential role in immunomodulation and neuroinflammation J Neuroimmune Pharmacol 8 2013 608 620
76. E.B. Russo, and T.H.C. Taming Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects Br J Pharmacol 163 2011 1344 1364
77. S. Salomonsen-Sautel, S.J. Min, J.T. Sakai, C. Thurstone, and C. Hopfer Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado Drug Alcohol Depend 140 2014 137 144
78. Sanchez YW: Medical marijuana purity under a microscope. Available at: http://www.usatoday.com/story/news/nation/2014/01/06/medical-marijuana-purity-laboratories/4336123. Accessed July 21, 2015
79. T. Schierenbeck, D. Riemann, M. Berger, and M. Hornyak Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana Sleep Med Rev 12 2008 381 389
80. J. Schuermeyer, S. Salomonsen-Sautel, R.K. Price, S. Balan, C. Thurstone, S.J. Min, and J.T. Sakai Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11 Drug Alcohol Depend 140 2014 145 155
81. N. Sehgal, L. Manchikanti, and H.S. Smith Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse Pain Physician 15 2012 ES67 ES92
82. D.A. Simonetto, A.S. Oxentenko, M.L. Herman, and J.H. Szostek Cannabinoid hyperemesis: A case series of 98 patients Mayo Clin Proc 87 2012 114 119
83. R.Q. Skrabek, L. Galimova, K. Ethans, and D. Perry Nabilone for the treatment of pain in fibromyalgia J Pain 9 2008 164 173
84. State of Oregon: Control, Regulation, and Taxation of Marijuana and Industrial Hemp Act. Available at: http://media.oregonlive.com/mapes/other/SP-2014-051.pdf. Accessed March 28, 2015
85. The University of Mississippi, National Center for Natural Products Research: Cannabis Research. Available at: http://pharmacy.olemiss.edu/ncnpr/research-programs/cannabis-research. Accessed July 21, 2015
86. G. Thomas, R.A. Kloner, and S. Rezkalla Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: What cardiologists need to know Am J Cardiol 113 2014 187 190
87. C. Toth, S. Mawani, S. Brady, C. Chan, C. Liu, E. Mehina, A. Garven, J. Bestard, and L. Korngut An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain Pain 153 2012 2073 2082
88. Ubelacker S: Quebec Cannabis Registry To Collect Data From Patients Using Medical Marijuana. Available at: http://www.huffingtonpost.ca/2015/05/11/quebec-registry-will-trac-n-7259620.html. Accessed July 21, 2015
89. United States Department of Justice, Drug Enforcement Administration, Office of Diversion Control: Controlled Substance Schedules. Available at: http://www.deadiversion.usdoj.gov/schedules/index.html#define. Accessed July 21, 2015
90. United States Department of Justice, Office of Public Affairs: Justice Department Announces Update to Marijuana Enforcement Policy. Available at: http://www.justice.gov/opa/pr/justice-department-announces-update-marijuana-enforcement-policy. Accessed July 21, 2015
91. Clinicaltrials.gov: Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease (Cannabis-SCD). Available at: https://clinicaltrials.gov/ct2/show/NCT01771731. Accessed July 21, 2015
92. G.A. van den Elsen, A.I. Ahmed, M. Lammers, C. Kramers, R.J. Verkes, M.A. van der Marck, and M.G. Rikkert Efficacy and safety of medical cannabinoids in older subjects: A systematic review Ageing Res Rev 14 2014 56 64
93. R. Vandrey, J.C. Raber, M.E. Raber, B. Douglass, C. Miller, and M.O. Bonn-Miller Cannabinoid dose and label accuracy in edible medical cannabis products JAMA 313 2015 2491 2493
94. N.D. Volkow, R.D. Baler, W.M. Compton, and S.R.B. Weiss Adverse health effects of marijuana use N Engl J Med 370 2014 2219 2227
95. M.M. Wall, E. Poh, M. Cerda, K.M. Keyes, S. Galea, and D.S. Hasin Adolescent marijuana use from 2002 to 2008: Higher in states with medical marijuana laws, cause still unclear Ann Epidemiol 21 2011 714 716
96. M.S. Wallace, T.D. Marcotte, A. Umlauf, B. Gouaux, and J.H. Atkinson Efficacy of inhaled cannabis on painful diabetic neuropathy J Pain 16 2015 616 627
97. G.S. Wang, G. Roosevelt, and K. Heard Pediatric marijuana exposures in a medical marijuana state JAMA Pediatr 167 2013 630 633
98. T. Wang, J.P. Collet, S. Shapiro, and M.A. Ware Adverse effects of medical cannabinoids: A systematic review CMAJ 178 2008 1669 1678
99. M.A. Ware, M.A. Fitzcharles, L. Joseph, and Y. Shir The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial Anesth Analg 110 2010 604 610
100. M.A. Ware, T. Wang, S. Shapiro, and J.P. Collet COMPASS study team: Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) J Pain 16 2015 1233 1242
101. M.A. Ware, T. Wang, S. Shapiro, A. Robinson, T. Ducruet, T. Huynh, A. Gamsa, G.J. Bennett, and J.P. Collet Smoked cannabis for chronic neuropathic pain: A randomized controlled trial CMAJ 182 2010 E694 E701
102. S.J. Watson, J.A. Benson Jr., and J.E. Joy Marijuana and medicine: Assessing the science base: A summary of the 1999 Institute of Medicine report Arch Gen Psychiatry 57 2000 547 552
103. WebMD: MARINOL Side Effects. Available at: http://www.webmd.com/drugs/2/drug-9308/marinol-oral/details/list-sideeffects. Accessed July 21, 2015
104. S.G. Weiner, L.C. Horton, T.C. Green, and S.F. Butler A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department Drug Alcohol Depend 159 2016 152 157
105. N.L. Wiedemer, P.S. Harden, I.O. Arndt, and R.M. Gallagher The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse Pain Med 8 2007 573 584
106. J.L. Wilkerson, and E.D. Milligan The central role of glia in pathological pain and the potential of targeting the cannabinoid 2 receptor for pain relief ISRN Anesthesiol 593894 2011 2011
107. S.T. Wilkinson, R. Radhakrishnan, and D.C. D'Souza Impact of cannabis use on the development of psychotic disorders Curr Addict Rep 1 2014 115 128
108. B. Wilsey, J.H. Atkinson, T.D. Marcotte, and I. Grant The medicinal cannabis treatment agreement: Providing information to chronic pain patients via a written document Clin J Pain 31 2015 1087 1096
109. B. Wilsey, T. Marcotte, R. Deutsch, B. Gouaux, S. Sakai, and H. Donaghe Low-dose vaporized cannabis significantly improves neuropathic pain J Pain 14 2013 136 148
110. B. Wilsey, T. Marcotte, A. Tsodikov, J. Millman, H. Bentley, B. Gouaux, and S. Fishman A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain J Pain 9 2008 506 521
111. World first: Launch of Quebec Registry for Cannabis Users. Press release of McGill University Health Centre. Available at: https://registrecannabisquebec.com/en/world-first-launch-quebec-registry-users-medical-cannabis. Accessed March 29, 2016
112. L.R. Zhang, H. Morgenstern, S. Greenland, S.C. Chang, P. Lazarus, M.D. Teare, P.J. Woll, I. Orlow, B. Cox Cannabis and Respiratory Disease Research Group of New Zealand Y. Brhane, G. Liu, and R.J. Hung Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium Int J Cancer 136 2015 894 903